Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug, and giving them after surgery, may
kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy, consisting of
paclitaxel and cisplatin, given after surgery in treating patients with cancer of the
esophagus or stomach.